Ocera Therapeutics, Inc. — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d7896e29-a93d-4aed-82ae-549989bc3a07/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2016 | $-26.9M | 2016-01-01 – 2016-12-31 | evidence 0001274644-17-000014 |
| FY 2015 | $-26.5M | 2015-01-01 – 2015-12-31 | evidence 0001274644-16-000107 |
| FY 2014 | $-23.4M | 2014-01-01 – 2014-12-31 | evidence 0001274644-15-000013 |
| FY 2013 | $-85.6M | 2004-12-20 – 2014-03-31 | evidence 0001274644-14-000009 |
| FY 2012 | $-3.6M | 2012-01-01 – 2012-12-31 | evidence 0001274644-14-000004 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Ocera Therapeutics, Inc. — all facts · Revenue · Operating Income